Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos

Molecular Brain Research

Volumn 70, Issue 1, 1999, Pages 45-53

  Chen, B ^a   Wang, J F ^a   Hill, B C ^a   Young, L T ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Bipolar disorder; c Fos; c Jun; CREB; Lithium; Phosphorylation; Valproate

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LITHIUM CHLORIDE; PROTEIN C FOS; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIPOLAR DEPRESSION; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM EXPOSURE; MALE; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; ANTIMANIC AGENTS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LITHIUM CHLORIDE; MALE; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC; VALPROIC ACID;

EID: 0033064346     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00125-4     Document Type: Article

References (38)

1. Arenander A.T., de Vellis J., Herschman H.R. Induction of c-fos and TIS genes in cultured rat astrocytes by neurotransmitters. J. Neurosci. Res. 24:1989;107-114.
2. Asghari V., Wang J.F., Reiach J.S., Young L.T. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 binding activity in human neuroblastoma SH-SY5Y cells. Mol. Brain Res. 58:1998;95-102.
3. Avissar S., Schreiber G., Danon A., Balmaker R.H. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature. 331:1988;440-442.
4. Berk A.J., Schmidt M.C. How do transcription factors work? Genes Dev. 4:1990;151-155.
5. Bowden C.L. Role of newer medications for bipolar disorder. J. Clin. Psychopharmacol. 16:1996;42S-45S. Suppl.
6. Carli M., Anand-Srivastava M.B., Molina-Holgado E., Dewar K.M., Reader T.A. Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Neurochem. Int. 24:1994;13-22.
7. Chen G., Yuan P., Hawver D.B., Potter W.Z., Manji H.K. Increase in AP-1 transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology. 16:1997;238-245.
8. Cirelli C., Pompeiano M., Tononi G. Neural gene expression in the waking state: a role for the locus coeruleus. Science. 274:1996;1211-1215.
9. Divish M.M., Sheftel G., Boyle A., Kalasapudi V.D., Papolos D.F. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action. J. Neurosci. Res. 28:1991;40-48.
10. Elias M.E., Margiotta M., Gaborc D. Sensitive and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. Am. J. Clin. Pathol. 92:1989;62-67.
11. Forn J., Valdecasas F.G. Effects of lithium on brain adenyl cyclase activity. Biochem. Pharmacol. 20:1971;2773-2779.
12. Ginty D.D., Kornhauser J.M., Thompson M.A., Bading H., Mayo K.E., Takahashi J.S., Greenbreg M.E. Regulation of CREB phosphorylation in the surprachiasmatic nucleus by light and a circadian clock. Science. 260:1993;238-241.
13. Gonzalaez G.A., Yamamoto K.Y., Fisher W.H., Karr D., Menzel P., Biggs W.I., Vale W.W., Montminy M.R. A cluster of phosphorylation sites on the cyclic AMP regulated nuclear factor CREB predicted by its sequence. Nature. 337:1994;749-752.
14. Herdegen T., Bastmeyer M., Bahr M., Bravo R., Sturmer C.A.O., Zimmermann M. Expression of JUN, KROX and CREB transcription factors in goldfish and rat ganglion cells following optic nerve lesions is related to axonal sprouting. J. Neurobiol. 24:1993;528-543.
15. Herdegen T., Brecht S., Mayer B., Leah J.D., Kummer W., Bravo R., Zimmermann M. Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy. J. Neurosci. 13:1993;4130-4145.
16. Herdegen T., Sandkuhler J., Gass P., Kissling M., Bravo R., Zimmermann M. JUN, FOS, KROX and CREB transcription factor proteins in the rat cortex: basal expression and induction by spreading depression and epileptic seizures. J. Comp. Neurol. 333:1993;271-288.
17. Jensen J.B., Mork A. Altered protein phosphorylation in the rat brain following chronic lithium and carbamazepine treatments. Eur. Neuropsychopharmacol. 7:1997;173-179.
18. Kalasapudi V.D., Sheftel G., Divish M.M., Papolos D.F., Lachman H.M. Lithium augments fos protooncogene expression in PC12 pheochromocytoma cells: implications for therapeutic action of lithium. Brain Res. 521:1990;47-54.
19. Lenox R.H., McNamara R.K., Watterson J.M., Watson D.G. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? J. Clin. Psychiatry. 57(13):1996;23-31. Suppl.
20. Li X., Jope R.S. Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J. Neurochem. 65:1995;2500-2508.
21. Li P.P., Young L.T., Tam Y.K., Sibony D., Warsh J.J. Effects of chronic lithium and carbamazepine treatment on G protein subunit expression in rat cerebral cortex. Biol. Psychiatry. 34:1993;167-170.
22. Li P.P., Young L.T., Warsh J.J. Lithium decreased Gs, Gi-1 and Gi-2 α-subunit mRNA levels in rat cortex. Eur. J. Pharmacol. Mol. Pharmacol. 206:1991;165-166.
23. Manji H., Potter W.A., Lenox R.H. Molecular targets for lithium's actions. Arch. Gen. Psychiatry. 52:1995;31-543.
24. McElroy S.L., Keck P.E. Jr., Pope H.G. Jr., Hudson J.I. Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. J. Clin. Psychopharmacol. 12:1992;42S-51. Suppl.
25. Mitchell P.J., Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 245:1989;371-378.
26. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16:1996;2365-2372.
27. Ozaki N., Chuang D.M. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J. Neurochem. 69:1997;2336-2344.
28. Schwaninger M., Schöfl C., Blume R., Rössig L., Knepel W. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol. 47:1995;1112-1118.
29. Shi Z.R., Itzkowitz S.H., Kim Y.S. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J. Histol. Cytol. 36:1988;317-322.
30. Sivram S.P., Takeuchi K., Li S., Douglass J., Civelli O., Calvetta L., Herbert E., McGinty J.F., Hong J.S. Mol. Brain Res. 3:1988;155-164.
31. T.A. Ketter, M.S. George, Kimbrell, M.W. Willis, B.E. Benson, R.M. Post, Neuroanatomical models and brain-imaging studies, in: L.T. Young, R.T. Joffe (Eds.), Bipolar Disorder, Marcel Dekker Press, New York, 1997, pp. 179-217.
32. Wang J.F., Young L.T. Differential display PCR reveals increased expression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase by lithium. FEBS Lett. 386:1996;225-229.
33. Wang J.F., Asghari V., Rockel C., Young L.T. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells. Neuroscience. 91:1999;771-776.
34. Wang J.F., Bown C., Young L.T. Differential display PCR reveals novel targets for the mood stabilizing drug valproate including the molecular chaperone GRP78. Mol. Pharmacol. 55:1999;521-527.
35. Weiner E.D., Mallat A.M., Papolos D.F., Lachman H.M. Mol. Brain Res. 12:1992;209-214.
36. Williams M.B., Jope R.S. Distinctive rat brain immediate early gene responses to seizures induced by lithium plus pilocarpine. Mol. Brain Res. 25:1994;80-89.
37. Yamamoto R., Toshihiko Y., Kobayashi H., Yokoo H., Wada A. Up-regulation of sodium channel subunit mRNAs and their cell surface expression by antiepileptic valproic acid: activation of calcium channel and catecholamine secretion in adrenal chromaffin cells. J. Neurochem. 68:1997;1655.
38. Zanardi R., Racagni G., Smeraldi E., Perez J. Differential effects of lithium on platelet protein phosphorylation in bipolar patients and healthy subjects. Psychopharmacology. 129:1997;44-47.